Pleomorphic lobular carcinoma of the breast: a comparison of cytopathological features with other lobular carcinoma variants

被引:10
|
作者
Ohashi, R. [1 ]
Matsubara, M. [1 ]
Watarai, Y. [1 ]
Yanagihara, K. [2 ]
Yamashita, K. [2 ]
Tsuchiya, S. -I. [1 ,3 ]
Takei, H. [2 ]
Naito, Z. [1 ,4 ]
机构
[1] Nippon Med Coll Hosp, Dept Diagnost Pathol, Tokyo, Japan
[2] Nippon Med Coll Hosp, Dept Breast Surg, Tokyo, Japan
[3] Iida Hosp, Dept Diagnost Pathol, Tokyo, Japan
[4] Nippon Med Sch, Dept Integrated Diagnost Pathol, Tokyo, Japan
关键词
pleomorphic lobular carcinoma; fine needle aspiration; cytology; FINE-NEEDLE-ASPIRATION; INVASIVE DUCTAL CARCINOMAS; OF-THE-LITERATURE; CYTOLOGIC DIAGNOSIS; IN-SITU; CANCER; EXPRESSION; EXPERIENCE; PITFALL; BIOPSY;
D O I
10.1111/cyt.12362
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Pleomorphic lobular carcinoma (PLC) is a subtype of breast cancer with unique morphological features, but it remains controversial whether PLC should be considered an independent disease entity. The aim of this study was to illustrate cytopathological characteristics of PLC in comparison with other lobular carcinoma variants. Methods: We investigated clinicopathological features of PLC (n = 11) compared with those of other variants of invasive lobular carcinoma (ILC, non-PLC) (n = 32). Histological variants of the non-PLC group consisted of classic (n = 25), solid (n = 2), alveolar (n = 1) and a tubulolobular type (n = 4). A review of cytological reports and fine needle aspiration (FNA) smear samples was performed for the PLC (n = 9) and non-PLC (n = 27) groups. Results: : Patients with PLC were older, and had a higher nuclear grade and a higher incidence of axillary lymph node metastasis and triple negative phenotype than non-PLC patients (P = 0.007, P < 0.001, P = 0.02 and P < 0.001, respectively). Cytological findings in PLC included medium-to large-sized nuclei, prominent nucleoli, a moderate-to-severe degree of pleomorphism, apocrine change and background necrosis, none of which were evident in the smears of the non-PLC group (P < 0.001, P = 0.002, P < 0.001, P < 0.001, and P = 0.03, respectively). Despite these differences, patients with PLC and non-PLC showed similar clinical outcomes in our follow-up period. Conclusions: Based on our results, a cytological diagnosis of PLC should be proposed if there are moderate-to large-sized nuclei, prominent nucleoli, a moderate-to severe degree of nuclear pleomorphism, apocrine change and necrosis in the background in FNA biopsy samples.
引用
收藏
页码:122 / 130
页数:9
相关论文
共 50 条
  • [41] LOBULAR CARCINOMA OF THE BREAST - CYTOLOGICAL FEATURES SUPPORTING THE DIAGNOSIS OF LOBULAR CANCER
    ROBINSON, IA
    MCKEE, G
    JACKSON, PA
    COOK, MG
    KISSIN, MW
    DIAGNOSTIC CYTOPATHOLOGY, 1995, 13 (03) : 196 - 201
  • [42] Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast:: A report of 24 cases
    Sneige, N
    Wang, JZ
    Baker, BA
    Krishnamurthy, S
    Middleton, LP
    MODERN PATHOLOGY, 2002, 15 (10) : 1044 - 1050
  • [43] Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma
    Narendra, Sonia
    Jenkins, Sarah M.
    Khoor, Andras
    Nassar, Aziza
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2015, 19 (02) : 64 - 69
  • [44] Carcinogenesis Pathways of Pleomorphic Lobular Carcinoma
    Lamzabi, I.
    Ghai, R.
    Reddy, V.
    Bitterman, P.
    Singh, R.
    Gattuso, P.
    MODERN PATHOLOGY, 2013, 26 : 52A - 52A
  • [45] Management of pleomorphic lobular carcinoma in situ
    Downs-Kelly, E.
    Bell, D.
    Sneige, N.
    Middleton, L. P.
    LABORATORY INVESTIGATION, 2008, 88 : 29A - 29A
  • [46] Carcinogenesis Pathways of Pleomorphic Lobular Carcinoma
    Lamzabi, I.
    Ghai, R.
    Reddy, V.
    Bitterman, P.
    Singh, R.
    Gattuso, P.
    LABORATORY INVESTIGATION, 2013, 93 : 52A - 52A
  • [47] Imaging Characteristics of Pleomorphic Lobular Carcinoma
    Sharma, A.
    Ananthakrishnan, P.
    Feldman, S. M.
    Taback, B.
    Vaz, A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S59 - S59
  • [48] Management of pleomorphic lobular carcinoma in situ
    Downs-Kelly, E.
    Bell, D.
    Sneige, N.
    Middleton, L. P.
    MODERN PATHOLOGY, 2008, 21 : 29A - 29A
  • [49] ULTRASTRUCTURAL AND IMMUNOHISTOCHEMICAL FEATURES OF LOBULAR CARCINOMA OF THE BREAST
    NESLAND, JM
    HOLM, R
    JOHANNESSEN, JV
    JOURNAL OF PATHOLOGY, 1985, 145 (01): : 39 - 52
  • [50] Significance of Lobular Features in Inflammatory Breast Carcinoma
    Onken, Allison
    Cleary, Allison
    Nakhlis, Faina
    Bellon, Jennifer
    Overmoyer, Beth
    Lynce, Filipa
    Harrison, Beth
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 174 - 175